Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-07-02

Clinical Trial Update: EXPAREL Administered by Infiltration Into the TAP for Prolonged Postsurgical Analgesia in Lower Abdominal Surgeries [Phase 4]

View source ↗

Summary

Phase 4 trial update on EXPAREL administered by infiltration into the TAP for prolonged postsurgical analgesia in lower abdominal surgeries; study terminated wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Exparel (liposomal bupivacaine)

Snippet

Sponsor: Pacira Pharmaceuticals, Inc | Conditions: Pain | Phase 4 | Status: TERMINATED | Results posted: 2021-07-02